Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
K. Kimura. (1993) Effect of a Somatostatin Analogue (SMS 201–995) on Antral Gastrin Cell Hyperplasia and Hypergastrinemia Induced by a Histamine H2-Receptor Antagonist. Scandinavian Journal of Gastroenterology 28:5, pages 413-417.
Read now
Read now
Articles from other publishers (22)
Loris Pironi, Cristina Cuerda, Palle Bekker Jeppesen, Francisca Joly, Cora Jonkers, Željko Krznarić, Simon Lal, Georg Lamprecht, Marek Lichota, Manpreet S. Mundi, Stéphane Michel Schneider, Kinga Szczepanek, André Van Gossum, Geert Wanten, Carolyn Wheatley & Arved Weimann. (2023) ESPEN guideline on chronic intestinal failure in adults – Update 2023. Clinical Nutrition 42:10, pages 1940-2021.
Crossref
Crossref
Palle Bekker Jeppesen. 2023. Intestinal Failure. Intestinal Failure
681
697
.
Palle Bekker Jeppesen. (2019) The Long Road to the Development of Effective Therapies for the Short Gut Syndrome: A Personal Perspective. Digestive Diseases and Sciences 64:10, pages 2717-2735.
Crossref
Crossref
Loris Pironi, Jann Arends, Federico Bozzetti, Cristina Cuerda, Lyn Gillanders, Palle Bekker Jeppesen, Francisca Joly, Darlene Kelly, Simon Lal, Michael Staun, Kinga Szczepanek, André Van Gossum, Geert Wanten & Stéphane Michel Schneider. (2016) ESPEN guidelines on chronic intestinal failure in adults. Clinical Nutrition 35:2, pages 247-307.
Crossref
Crossref
Stephen J. Marx & Samuel A. WellsJr.Jr.. 2016. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology
1723
1761.e3
.
Palle Bekker Jeppesen. 2016. Current Concepts of Intestinal Failure. Current Concepts of Intestinal Failure
79
96
.
Stephen J. Marx & Samuel A. WellsJr.Jr.. 2011. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology
1728
1767
.
A. Lamrani, N. Vidon, P. Sogni, P. Nepveux, F. Catus, J. Blumberg & S. Chaussade. (2008) Effects of lanreotide, a somatostatin analogue, on postprandial gastric functions and biliopancreatic secretions in humans. British Journal of Clinical Pharmacology 43:1, pages 65-70.
Crossref
Crossref
A. Lamrani, N. Vidon, P. Sogni, P. Nepveux, F. Catus, J. Blumberg & S. Chaussade. (1997) Effects of lanreotide, a somatostatin analogue, on postprandial gastric functions and biliopancreatic secretions in humans. British Journal of Clinical Pharmacology 43:1, pages 65-70.
Crossref
Crossref
Pierre Martineau, Jill A. Shwed & Ronald Denis. (1996) Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?. The American Journal of Surgery 172:4, pages 386-395.
Crossref
Crossref
J.D. Stephen, Keefe O'Maren E. Peterson & C. Richard Fleming. (2016) Octreotide as an Adjunct to Home Parenteral Nutrition in the Management of Permanent End-Jejunostomy Syndrome. Journal of Parenteral and Enteral Nutrition 18:1, pages 26-34.
Crossref
Crossref
J.D. Stephen, Keefe O'Maren E. Peterson & C. Richard Fleming. (2016) Octreotide as an Adjunct to Home Parenteral Nutrition in the Management of Permanent End-Jejunostomy Syndrome. Journal of Parenteral and Enteral Nutrition 18:1, pages 26-34.
Crossref
Crossref
K.E. Gyr & R. Meier. (1992) Pharmacodynamic effects of Sandostatin® in the gastrointestinal tract. Metabolism 41:9, pages 17-21.
Crossref
Crossref
Alan G. Harris. (2012) Octreotide in the Treatment of Disorders of the Gastrointestinal System. Drug Investigation 4:S3, pages 1-54.
Crossref
Crossref
W. E. KARNES, V. MAXWELL, B. SYTNIK, P. CHEW & J. H. WALSH. (2007) Prolonged inhibition of meal‐stimulated acid secretion and gastrin release following single subcutaneous administration of octreotide (SMS 201–995) in man. Alimentary Pharmacology & Therapeutics 3:6, pages 527-538.
Crossref
Crossref
Paul N. Maton. (1989) The Use of the Long-Acting Somatostatin Analogue, Octreotide Acetate, in Patients with Islet Cell Tumors. Gastroenterology Clinics of North America 18:4, pages 897-922.
Crossref
Crossref
J. M. D. NIGHTINGALE, E. R. WALKER, W. R. BURNHAM, M. J. G. FARTHING & J. E. LENNARD-JONES. (2007) Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Alimentary Pharmacology & Therapeutics 3:4, pages 367-373.
Crossref
Crossref
Paul N. Maton, Jerry D. Gardner & Robert T. Jensen. (1989) Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors. Digestive Diseases and Sciences 34:S3, pages S28-S39.
Crossref
Crossref
F. László, I. Pávó, B. Penke & G.A. Bálint. (1989) Protective effect of an orally administered, highly potent somatostatin analog (RC-121) against absolute ethanol-induced hemorrhagic erosions of the rat gastric mucosa. Life Sciences 44:21, pages 1573-1578.
Crossref
Crossref
Paul N. Maton. 1989. Modern Concepts in Gastroenterology Volume 2. Modern Concepts in Gastroenterology Volume 2
109
127
.
D H Presky & A Schonbrunn. (1988) Somatostatin pretreatment increases the number of somatostatin receptors in GH4C1 pituitary cells and does not reduce cellular responsiveness to somatostatin.. Journal of Biological Chemistry 263:2, pages 714-721.
Crossref
Crossref
R. G. LONG. (2007) Review: long‐acting somatostatin analogues. Alimentary Pharmacology & Therapeutics 1:3, pages 191-200.
Crossref
Crossref